We have measured the changes in transient otoacoustic emissions (TEOAE
s) and distortion product otoacoustic emissions (DPOAEs) during and af
ter ototoxic amikacin treatment in an animal (chinchilla) model. TEOAE
and DPOAE were recorded from 6 adult chinchillas over a 6-week time c
ourse starting just before a 5-day or 7-day treatment period with amik
acin sulphate (400 mg/kg/day, i.m.). After final recordings, cochlear
morphology was assessed by scanning electron microscopy. Generally, bo
th DPOAE and TEOAE amplitudes change during and after treatment in a s
ystematic fashion. High-frequency components change first, followed by
lower-frequency components. We note that there is often a long latenc
y to the onset of changes in otoacoustic emissions (OAE), and that the
se changes can continue for weeks after treatment. Most importantly we
report that when the basal region of the cochlea is damaged in the fr
equency region above the OAE recording bandwidth (0.6-6 kHz for TEOAE;
1-6.7 kHz for DPOAE), we often find an increase in OAE amplitudes. Mo
re specifically, we note that as a cochlear lesion progresses apically
, there is often a transient increase in a frequency-specific OAE befo
re it reduces or is lost. Our results suggest that the increase in OAE
amplitudes precedes the expression of detectable cochlear pathology.